Hrt Financial LP Zoetis Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$165.67 - $199.94 $870,264 - $1.05 Million	5,253 New	5,253 $888,000
Q4 2022 Feb 10, 2023	BUY	$131.14 - $157.47 $10.1 Million - $12.1 Million	76,763 Added 584.24%	89,902 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $1.95 Million - $2.4 Million	13,139 New	13,139 $1.95 Million
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $32.2 Million - $41.4 Million	-206,693 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $37.5 Million - $48.4 Million	206,693 New	206,693 $39 Million
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $1.17 Million - $1.49 Million	-10,446 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$92.66 - $144.94 $463,855 - $725,569	5,006 Added 92.02%	10,446 $1.23 Million
Q2 2018 Aug 15, 2018	BUY	$79.9 - $89.2 $434,656 - $485,248	5,440 New	5,440 $463,000

1,897

423M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $91.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.